The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Bleomycin-Induced Pneumonitis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A., & Shepard, H. M. (1985) · Science · doi:10.1126/science.3933111 · Cited by 1,580
Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD
Canellos, G. P., Anderson, J. R., Propert, K. J., Nissen, N., Cooper, M. R., Henderson, E. S., Green, M. R., Gottlieb, A., & Peterson, B. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272102 · Cited by 1,148
A clinical review of bleomycin—a new antineoplastic agent
Blum, R. H., Carter, S. K., & Agre, K. (1973) · Cancer · doi:10.1002/1097-0142(197304)31:4<903::aid-cncr2820310422>3.0.co;2-n · Cited by 864
Interleukin 1, a potential regulator of fibroblast proliferation.
Schmidt, J. A., Mizel, S. B., Cohen, D., & Green, I. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.128.5.2177 · Cited by 831
New antibiotics, bleomycin A and B.
Umezawa, H., Maeda, K., Takeuchi, T., & Okami, Y. (1966) · PubMed · Cited by 725
Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
Piguet, P. F., Collart, M. A., Grau, G. E., Kapanci, Y., & Vassalli, P. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.655 · Cited by 583
The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Adamson, I. Y. R., & Bowden, D. H. (1974) · PubMed Central · Cited by 479
Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA.
Burger, R. M., Peisach, J., & Horwitz, S. B. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68452-8 · Cited by 462
Giri, S. N., Hyde, D. M., & Hollinger, M. A. (1993) · Thorax · doi:10.1136/thx.48.10.959 · Cited by 402
Einhorn, L. H., Williams, S. D., Loehrer, P. J., Birch, R., Drasga, R., Omura, G., & Greco, F. A. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.3.387 · Cited by 367
Effect of chelating agents and metal ions on the degradation of DNA by bleomycin
Sausville, E. A., Peisach, J., & Horwitz, S. B. (1978) · Biochemistry · doi:10.1021/bi00607a007 · Cited by 366
Nichols, C. R., Catalano, P. J., Crawford, E. D., Vogelzang, N. J., Einhorn, L. H., & Loehrer, P. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1287 · Cited by 348
Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis
Kuwano, K., Hagimoto, N., Kawasaki, M., Yatomi, T., Nakamura, N., Nagata, S., Suda, T., Kunitake, R., Maeyama, T., Miyazaki, H., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5628 · Cited by 345
Properties and products of the degradation of DNA by bleomycin and iron(II)
Sausville, E. A., Stein, R. W., Peisach, J., & Horwitz, S. B. (1978) · Biochemistry · doi:10.1021/bi00607a008 · Cited by 337
Lung Cytokine Production in Bleomycin-Induced Pulmonary Fibrosis
Phan, S. H., & Kunkel, S. L. (1992) · Experimental Lung Research · doi:10.3109/01902149209020649 · Cited by 323
Gurujeyalakshmi, G., & Giri, S. N. (1995) · Experimental Lung Research · doi:10.3109/01902149509050842 · Cited by 303
Bleomycin, an Antitumor Antibiotic: Clinical Experience in 274 Patients
YAGODA, A., MUKHERJI, B., YOUNG, C., ETCUBANAS, E., LAMONTE, C., SMITH, J. R., TAN, C. T. C., & KRAKOFF, I. H. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-6-861 · Cited by 286
Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice.
Hagimoto, N., Kuwano, K., Nomoto, Y., Kunitake, R., & Hara, N. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.1.8998084 · Cited by 274
Bleomycin-Induced Pulmonary Toxicity
Jules-Elysee, K., & White, D. A. (1990) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)00668-7 · Cited by 253
Loehrer, P. J., Johnson, D., Elson, P., Einhorn, L. H., & Trump, D. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.2.470 · Cited by 245
Oxygen radicals in lung pathology
Doelman, C. J. A., & Bast, A. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90015-b · Cited by 218
Piguet, P. F., Vesin, C., Grau, G. E., & Thompson, R. C. (1993) · Cytokine · doi:10.1016/1043-4666(93)90024-y · Cited by 215
Zhang, K., Flanders, K. C., & Phan, S. H. (1995) · Europe PMC (PubMed Central) · Cited by 190
Severe Bleomycin-Induced Pneumonitis
White, D. A., & Stover, D. E. (1984) · CHEST Journal · doi:10.1378/chest.86.5.723 · Cited by 146
Santana, A., Saxena, B., Noble, N. A., Gold, L. I., & Marshall, B. C. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.13.1.7541221 · Cited by 135
Lena, M. D., Guzzon, A., Monfardini, S., & Bonadonna, G. (1972) · PubMed · Cited by 125
Continuous Infusion or Bolus Injection in Cancer Chemotherapy
Carlson, R. W., & Sikic, B. I. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-6-823 · Cited by 114
Lung damage from cytotoxic drugs
Collis, C. (1980) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00255453 · Cited by 111
Sugahara, K., Iyama, K.-I., Kuroda, M. J., & Sano, K. (1998) · The Journal of Pathology · Cited by 103
Stimulation of rat endothelial cell transforming growth factor-beta production by bleomycin.
Phan, S. H., Gharaee‐Kermani, M., Wolber, F., & Ryan, U. S. (1991) · Journal of Clinical Investigation · doi:10.1172/jci114964 · Cited by 101
Bleomycin stimulation of cytokine secretion by the human alveolar macrophage
Scheule, R. K., Perkins, R. C., Hamilton, R. F., & Holian, A. (1992) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1992.262.4.l386 · Cited by 96
Schirner, M., Hoffmann, J., Menrad, A., & Schneider, M. R. (1998) · PubMed · Cited by 95
Sharma, S. K., MacLean, J. A., Pinto, C., & Kradin, R. L. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.1.8680680 · Cited by 92
Phan, S. H., Gharaee‐Kermani, M., McGarry, B. M., Kunkel, S. L., & Wolber, F. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.1.103 · Cited by 82
Bleomycin pulmonary toxicity: current status and future directions.
Comis, R. L. (1992) · PubMed · Cited by 72
Piguet, P. F., Rosen, H., Vesin, C., & Grau, G. E. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.2.435 · Cited by 64
Augmentation of fibroblast proliferation by bleomycin.
Moseley, P. L., Hemken, C., & Hunninghake, G. W. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112695 · Cited by 58
Bleomycin lung damage: The pathology and nature of the lesion
Jones, A. W. (1978) · British Journal of Diseases of the Chest · doi:10.1016/0007-0971(78)90061-x · Cited by 46
Bleomycin clinical pharmacology by radioimmunoassay
Hall, S. W., Strong, J. E., Broughton, A., Frazier, M. L., & Benjamin, R. S. (1982) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00296756 · Cited by 38
Herman, E. (1995) · Toxicology · doi:10.1016/0300-483x(94)02987-6 · Cited by 31
Detecting bleomycin pulmonary toxicity: a continued conundrum.
Comis, R. L. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.5.765 · Cited by 27
PULMONARY TOXICITY AFTER TREATMENT WITH BLEOMYCIN ALONE OR IN COMBINATION WITH HYPEROXIA
BLOM-MUILWIJK, M. C., Vriesendorp, R., Veninga, T. S., Hofstra, W., Sleyfer, D. T., WIERINGA, R. A., & Konings, A. W. T. (1988) · British Journal of Anaesthesia · doi:10.1093/bja/60.1.91 · Cited by 26
Effect of Immunomodulators on Bleomycin-Induced Lung Injury
Kremer, S., Breuer, R., Lossos, I. S., Berkman, N., Christensen, T. G., Connor, M. W., Goldstein, R. H., & Or, R. (1999) · Respiration · doi:10.1159/000029410 · Cited by 26
Nettelbladt, O., Tengblad, A., & Hällgren, R. (1990) · European Respiratory Journal · doi:10.1183/09031936.93.03040421 · Cited by 23
Amelioration of Bleomycin-Induced Pulmonary Injury by Cyclosporin A
Lossos, I. S., Or, R., Goldstein, R. H., Conner, M. W., & Breuer, R. (1996) · Experimental Lung Research · doi:10.3109/01902149609031779 · Cited by 22
THE EFFECT OF ENOXAPARIN ON BLEOMYCIN-INDUCED LUNG INJURY IN MICE
Lossos, I. S. (1999) · Experimental Lung Research · doi:10.1080/019021499270114 · Cited by 21
Treatment of disseminated non-seminomatous testicular cancer: The European experience
de Wit, R. (1999) · Seminars in Surgical Oncology · doi:10.1002/(sici)1098-2388(199912)17:4<250::aid-ssu5>3.0.co;2-m · Cited by 13
Cited by
Pulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822
Carver, J. R., Shapiro, C. L., Ng, A., Jacobs, L., Schwartz, C., Virgo, K. S., Hagerty, K. L., Somerfield, M. R., & Vaughn, D. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.9777 · Cited by 793
Bleomycins: towards better therapeutics
Chen, J., & Stubbe, J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1547 · Cited by 664
Cytokines and their relationship to the symptoms and outcome of cancer
Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2507 · Cited by 652
Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions
Della Latta, V., Cecchettini, A., Del Ry, S., & Morales, M. A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.04.012 · Cited by 514
Metadata
- Authors
- Sleijfer, S.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2001-08
- Volume
- 120
- Issue
- 2
- Pages
- 617-624
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2099297962
- Cited by
- 611
- References
- 47
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.